Y-Intercept (HK)’s Regenxbio RGNX Stock Holding History

Y-Intercept (HK)’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.47M	Buy	195,624 +14,153	+8%	+$144K	0.03%	788
2026 Q2	$2.17M	Sell	181,471 -93,550	-34%	-$776K	0.04%	652
2026 Q1	$2.3M	Buy	+275,021	New	+$2.89M	0.04%	651
2025 Q3	–	Sell	-176,999	Closed	-$1.45M	–	1962
2025 Q2	$1.45M	Buy	+176,999	New	+$1.48M	0.04%	757
2025 Q1	–	Sell	-137,402	Closed	-$1.06M	–	1542
2024 Q4	$1.06M	Buy	+137,402	New	+$1.29M	0.07%	404
2024 Q3	–	Sell	-38,844	Closed	-$454K	–	1728
2024 Q2	$454K	Buy	+38,844	New	+$605K	0.02%	858
2023 Q1	–	Sell	-11,859	Closed	-$269K	–	1476
2022 Q4	$269K	Buy	+11,859	New	+$268K	0.04%	710

Other funds holding RGNX

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

MIC

Maxi Investments CY Limassol, Cyprus $545M AUM 21.2% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Harbor Capital Advisors Chicago, Illinois $1.48B AUM 30.88% 1-Year Est. Return

Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return

Achmea Investment Management Zeist, Netherlands $12.6B AUM 25.68% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $57B AUM 43.56% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Y-Intercept (HK)'s RGNX Position: Q3 2026 in Review

Y-Intercept (HK) increased its Regenxbio (RGNX) stake by 7.8% in Q3 2026, buying an estimated $144K and bringing the position to 195,624 shares worth $1.47M. The position accounts for 0.03% of the portfolio, ranked #788.

Y-Intercept (HK) first reported a position in RGNX in Q4 2022 and has held it in 7 quarters since. The position peaked at $2.3M in Q1 2026. 31 funds tracked by Wall St. Rank hold RGNX as of Q3 2026.

Y-Intercept (HK) held 195,624 shares of Regenxbio worth $1.47M as of Q3 2026.
Y-Intercept (HK) bought 14,153 Regenxbio shares in Q3 2026, an estimated $144K.
Regenxbio made up 0.03% of Y-Intercept (HK)'s portfolio in Q3 2026, its #788 holding.
Y-Intercept (HK) first reported a position in Regenxbio in Q4 2022 and has held it in 7 quarters since.
Y-Intercept (HK)'s Regenxbio position peaked at $2.3M in Q1 2026.
31 funds tracked by Wall St. Rank held Regenxbio as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.